990
Participants
Start Date
October 18, 2022
Primary Completion Date
January 31, 2027
Study Completion Date
January 31, 2027
Return of Genetic Results: Biomarker information from cancer cells
Participants will receive a novel return of results report that is tailored to their choices.
Return of Genetic Results: Inherited mutations related to cancer
Participants will receive a novel return of results report that is tailored to their choices.
Return of Genetic Results: Inherited mutations related to other medical issues
Participants will receive a novel return of results report that is tailored to their choices.
RECRUITING
Washington University School of Medicine, St Louis
National Cancer Institute (NCI)
NIH
The Foundation for Barnes-Jewish Hospital
OTHER
Washington University School of Medicine
OTHER